Confocal backscattering spectroscopy for leukemic and normal blood cell discrimination

Area of Science:

• Biomedical Optics
• Hematology
• Cancer Diagnostics

Background:

• Leukemia is the most common pediatric cancer, driving significant research into improved diagnostic and risk assessment tools.
• Accurate assessment of leukemic cells is crucial for enhancing treatment strategies and improving cure rates in pediatric leukemia.
• Current methods for cell assessment can be improved through advanced optical techniques.

Purpose of the Study:

• To design and evaluate a confocal laser-based system for discriminating leukemic cells from normal red blood cells (RBC) and white blood cells (WBC).
• To leverage spectral differences in light scattering for enhanced cell identification.
• To explore the potential of this system for in vivo and in vitro applications in leukemia detection and monitoring.

Main Methods:

• Development of a confocal laser system collecting backscattered light at 405, 488, and 633 nm over a 26° range.
• Utilizing spectral differences observed from spectroscopy measurements with a white light source for system design.
• Analyzing intensity and wavelength dependence of light scattering from leukemic cells, RBCs, and WBCs.

Main Results:

• Significant differences in light scattering intensity and wavelength dependence were observed between leukemic cells and normal RBCs/WBCs.
• Red blood cell scattering is distinct due to hemoglobin absorption, aiding discrimination.
• Leukemic cells exhibit steeper light scattering spectra compared to normal WBCs, potentially due to intracellular fractal organization.

Conclusions:

• The developed laser-based system can effectively discriminate leukemic cells from normal blood components.
• Distinct light scattering properties provide a basis for sensitive and specific leukemia cell detection.
• The system holds potential for non-invasive, real-time monitoring of leukemia in microfluidic devices for disease management.